Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol ED50 with Esketamine for LMA Insertion
NCT06370130Phase 1Completed
- Sponsor
- Aerospace Center Hospital
- Start
- May 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of esketamine in Anesthesia (2 arms), sponsored by Aerospace Center Hospital. Primary endpoints: Patient response during LMA placement at 1 minute and Adverse reactions during induction at 1 minute. Started May 2022; status: completed.
02
Drugs
esketamine
03
Conditions
Anesthesia
Beyond the preview
Go deeper on NCT06370130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06370130.